Ionotropic glutamate receptors are tetrameric protein complexes that transduce chemical signals carried by neurotransmitter molecules into electrical impulses propagated in the postsynaptic neuron. Each protein subunit includes an N-terminal domain (ATD) and a cytoplasmic C-terminal domain (CTD), which are involved in receptor assembly, trafficking and regulation, a transmembrane domain (TMD) that forms the membrane-spanning ion channel, and a ligand-binding domain (LBD) that is key to channel gating 1 . The binding of agonist molecules to the LBDs drives the opening of the transmembrane pore, thereby allowing cations to flow across the cell membrane to trigger the generation of a nerve impulse. Full agonists such as glutamate have the highest levels of efficacy at the receptor, whereas antagonists block receptor activation and partial agonists produce submaximal responses when applied at saturating concentrations.
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The LBD is a flexible, clamshell-shaped protein that makes a conformational transition from an open to a closed state when it binds an agonist molecule in the cleft that separates its two lobes. Four LBDs are tethered to the TMD by short linkers, and when the LBDs close down to encapsulate the ligand, the local conformational change is assumed to force the opening of the transmembrane channel 2 . It is important to understand how the binding of different ligands leads to or inhibits the activation of the receptor. One possible mechanism, inferred from crystal structures of LBD-ligand complexes, is that ligand efficacy is directly correlated with the amount of cleft closure induced by the bound ligand 3 . There are discrepancies, however, which are not fully understood. For example, the LBDs of the GluN1 and GluK1 subunits have been shown to close fully even when bound to partial agonists 4, 5 . The relative twist between the two lobes has also been suggested to be important [6] [7] [8] . Such observations suggest that a purely 'structural' explanation that is based solely on cleft closure is not completely satisfactory.
Alternatively, a 'dynamical' mechanistic perspective might be that full agonists succeed in tightly closing the clamshell through strong interactions between the LBD and the ligand, whereas bound partial agonists exert only weak cleft-closing forces and thus cannot prevent transient fluctuations that lead to partial reopening of the LBD. The measured binding affinities of some antagonists to the isolated GluA2 LBD are stronger than the affinities of some agonists, which suggest that only a fraction of the total binding free energy is available to close the LBD and activate the receptor 3, 9 . The efficacy of an agonist can also be modulated by the stability of the closed LBDagonist complex [10] [11] [12] [13] .
A contrast can be drawn between the structural and dynamical views, in which function is explained either by X-ray structures of the LBD in complex with different ligands or by the fluctuations and transient excursions of the LBD away from a static conformation, although both are necessarily oversimplified. Nevertheless, it is difficult to achieve a deeper understanding of the mechanism of activation of iGluR receptors without a detailed dissection of the different thermodynamic contributions associated with ligand binding and LBD closure, which provide the link between structure and dynamics. Although such thermodynamic information is central to understanding the activation mechanism of ligand-gated receptors, it is difficult to access directly by experimental means and remains essentially 'hidden' from direct observations. We have determined the free energy contributions that govern the distinct subprocesses of ligand docking and LBD closure for the Rattus norvegicus GluA2 receptor with nine different ligands using all-atom molecular dynamics simulations with explicit solvent molecules. We used the results to analyze LBD conformational distributions in the context of a fulllength receptor and found key structural asymmetries that might influence activation. a r t i c l e s
RESULTS

Ligand-binding free energy calculations
To provide a broad perspective on the different modes of ligand action on the GluA2 receptor, we characterized the binding of three full agonists, three partial agonists and three antagonists (Fig. 1 ) using all-atom molecular dynamics simulations with explicit solvent. We computed the absolute binding free energies between each ligand and the flexible LBD as the sum of separate contributions corresponding to different steps of the ligand-binding process (see Online Methods). This computational approach, which was based on umbrella sampling potential of mean force (PMF) calculations, follows from a rigorous statistical mechanical formulation of noncovalent binding 14 (see Supplementary Methods, Theory). This procedure, which involves applied restraints, limits the amount of configurational space the ligand must sample while rigorously accounting for the associated free energies ( Fig. 2 and Supplementary Figs. 1 and 2) . The computations represent a total aggregate simulation time of ~1 µs.
Spectroscopic and stopped-flow kinetic analyses indicate that ligands dock into a pocket formed by residues Pro478, Thr480 and Arg485 in lobe 1 before forming additional interactions with residues in lobe 2 (refs. 9,15,16) . In the ligand-docking simulations, the LBD was restrained to an open conformation that allows a ligand to access its docking site ((ξ 1 , ξ 2 ) = (14.4 Å, 13.7 Å)). Atomic-scale fluctuations around the open conformation are sampled, but closure of the LBD is not permitted. This conformation is within the computed free energy basin of the apo LBD and is therefore predicted to be visited frequently by the protein before ligand docking ( Fig. 2 and Supplementary Fig. 3 ).
The free energy contributions from both ligand docking (∆G dock
and LBD closure (∆G close ) are required to correctly calculate the binding affinity between a ligand and a flexible protein. The docking step, by itself, was insufficient to predict affinity, as evidenced by the lack of correlation between ∆G dock ( )  and the experimentally measured binding free energies (Fig. 3a) . This is expected because docking is only one of several contributions that must be taken into account (see equation (1) in Online Methods). There was a moderate correlation between ∆G close and the experimental values ( Fig. 3b) , but a very strong correlation when we considered the sum of the docking and LBD closure components, Fig. 3c) . The correlation coefficient R 2 was 0.879, with a slope of 1.039, implying that the computed binding affinities agree well with experimental measurements. Glutamate and thio-ATPA (see Fig. 1 for details of ligands) had positive values of ∆G dock , indicating that docking into the LBD from bulk solvent is an unfavorable process for these two ligands (Fig. 3a) . However, the substantial gain in free energy from LBD closure compensated for the unfavorable ∆G dock ( )  and resulted in a favorable ∆G bind (Fig. 3b,c) . The antagonists CNQX 17 . The fact that CNQX had a broader free energy basin than DNQX was also consistent with the hydrogen deuterium exchange measurements, reflecting lobe dynamics for CNQX that are not observed for DNQX. A practical issue is whether the charged ligands tend to change their protonation states upon binding to the LBD. Free energy perturbation (FEP) calculations indicated that the ionizable groups on the ligands can be modeled to retain their bulk solvent protonation states, even when fully bound (Fig. 1, Supplementary Table 2 and Supplementary Methods). These states agree with Fourier transform infrared measurements 18 . Calculation of the binding free energy for alternate protonation states of AMPA and 4-AHCP-states determined to be inappropriate-gave values that agreed less well with the experimental measurements (Supplementary Table 3 ).
Free energy landscapes are key for evaluating binding
Having validated the computational methodology and the molecular dynamics simulations by comparing the results of the calculations with experimentally measured dissociation constants for nine ligands, we investigated the role of the individual free energy contributions that are 'hidden' in the total binding free energy on receptor activation. In particular, we asked whether the amount of free energy associated with LBD closure ∆G close -clearly a key component in receptor activation-is accurately reflected in crystal structures of the LBD-ligand complexes.
The calculated ∆G close and the extent of LBD closure seen in the crystal structures relative to the AMPA-bound structure were only weakly correlated (R 2 = 0.569; Supplementary  Fig. 4) , suggesting that the extent of closure, by itself, cannot account for the free energy associated with the protein's conformational transition. Therefore, the LBD free energy landscapes (Fig. 2) seem to be crucial for assessing ∆G close .
All the free energy landscapes featured a single major free energy basin. The locations of the global free energy minima for the nine ligands were in good agreement with the crystal structure conformations of each LBD-ligand complex. The largest discrepancy was observed for kainate, where the predicted 'most favored' LBD conformation was more open than observed crystallographically ((∆ξ 1 , ∆ξ 2 ) = (1.2 Å, 1.4 Å)), the crystal structure conformation being higher in free energy by ~1.8 kcal mol −1 . The kainate landscape suggested that this weak partial agonist may stabilize a relatively open LBD conformation, but rare transitions to more closed conformations could trigger channel activation. The locations of these minima for the nine ligands were generally segregated as expected when ranked in terms of the effective one-dimensional coordinate (ξ 1 + ξ 2 )/2: full agonists < partial agonists < antagonists (Fig. 2 and Supplementary Table 4) .
The detailed topological features in the different landscapes, as well as the number and shapes of shallow metastable states that surrounded the basins, differed among the nine ligands, even within the full agonist, partial agonist and antagonist classes. A metastable state 
In each plot, the solid line, which has a slope of 1, indicates perfect agreement between the calculated and experimental values. The dashed lines are linear regression fits to the data, and their slopes and correlation coefficients are shown. Each ligand is marked numerically in increasing order from the highest experimentally measured affinity to the lowest (Supplementary Table 1 in the glutamate landscape that corresponds to the largest cleft opening at which the ligand forms interactions with both lobes 1 and 2 has been described 19 . This conformation is (ξ 1 , ξ 2 ) ≈ (12.0 Å, 11.0 Å). We found topological features resembling finger-like extensions from the free energy basin in a similar location in the AMPA, thio-ATPA and 4-AHCP landscapes (Fig. 2 and Supplementary Fig. 5 ). The topologies of the glutamate and thio-ATPA landscapes suggest that LBD closure from (ξ 1 , ξ 2 ) = (12.0 Å, 11.0 Å) proceed first along ξ 2 and then along ξ 1 . Conversely, the AMPA landscape suggests closure first along ξ 1 followed by ξ 2 . Either trajectory seems plausible for 4-AHCP. The broad, shallow basin for ACPA suggests a more diffuse pathway of closure. For kainate and the antagonists, (ξ 1 , ξ 2 ) = (12.0 Å, 11.0 Å) is near the free energy minimum. Free energy landscapes for two LBD mutants, T686A and T686S, have been described 19 and were consistent with experimental evidence that Thr686 mutations destabilize cleft closure 10 .
LBD conformational distributions in an intact receptor
It is of interest to investigate how the local conformational change in the LBD might affect the TMD in the context of an intact full-length receptor using the present set of molecular dynamics free energy landscapes. To address this question, we transposed LBD snapshots spanning the free energy landscapes taken from the molecular dynamics simulations onto the crystal structure of an intact GluA2 receptor 2 (Fig. 4a) . We superimposed only the residues in lobe 1 of the LBD, thereby preserving the back-to-back dimer interfaces as well as the relative dispositions of all four LBDs with respect to the ATDs. We assembled all tetrameric combinations of snapshot configurations. We obtained the proper Boltzmann weight of each snapshot, p(ξ 1 , ξ 2 ), directly from the free energy land-
], where β −1 = k B T is the Boltzmann constant multiplied by temperature. This structural analysis therefore reflects an equilibrium ensemble of the complexes in the different accessible states, and also assumes that each LBD opens and closes independently of the others. We then calculated the following Boltzmann-weighted displacements: the root-mean-squared (r.m.s.) displacement between the superimposed LBD tetramer and the LBD tetramer from the crystallized GluA2 receptor; and the six pairwise distances between the LBDs. The r.m.s. displacements and distances involve a selection of residues in lobe 2 near the region that connects to the TMD (see Online Methods). We measured the r.m.s. displacement with respect to the Cα atoms, and the pairwise distances between the centers of mass of these atoms. The LBDs of the intact GluA2 structure are in open conformations as they are bound to the antagonist ZK200775 (ref. 20) . LBD-agonist conformations deviated more than the LBD-antagonist or apo LBD conformations. Histograms of the Boltzmann-weighted r.m.s. displacement measurements in the LBDs for the holo and apo forms are shown in Figure 4b . Overall, the averages of the r.m.s. displacement distributions came up as expected, with full agonists > partial agonists > antagonists (Supplementary Table 5 ). For some ligands, such as glutamate, the average r.m.s. displacement closely agreed with that obtained by directly superimposing the LBD-ligand crystal structure. For other ligands, such as AMPA, and for the apo LBD, there were pronounced differences between the thermal averages and the crystal structures. These differences suggest that the crystal structure conformations of the different LBD-ligand complexes do not always quantitatively account for the amount of conformational change that ligand binding can transmit to the TMD. For example, the LBD-AMPA crystal structure underestimated the average amount of conformational change the LBD samples upon binding AMPA, and the LBD-kainate crystal structure overestimated it. As the (ξ 1 , ξ 2 ) corresponding to the computed global free energy minima agreed well with the (ξ 1 , ξ 2 ) of the respective crystal structures (Supplementary  Table 4) , the differences in the r.m.s. displacement distributions arises necessarily from the features in the free energy landscapes that govern LBD closure.
A different perspective on the amount of useful work that the LBDs can transmit to the TMD is revealed by considering the Boltzmannweighted pairwise distances between lobes 2 for the holo and apo LBDs. Histograms of these measurements (Fig. 5) provide mechanistic inferences in terms of the amount of conformational change that can be transmitted to the ion-channel gate by ligand-bound LBDs in the context of a full-length receptor. The antagonist and apo distributions were clearly distinct from the full agonist distributions, although there was some overlap in the tails. The width of the distribution is related to how strongly the ligand stabilizes the LBD conformation around Figure 5 Inter-LBD distance distributions. LBD conformations were superimposed onto the intact GluA2 structure (Fig. 4) , and the pairwise distances were measured between regions in lobe 2 (see Online Methods). The apo LBD is gray, the LBD-antagonist complexes are blue and the LBD-full agonist complexes are red. The LBD-partial agonist complexes for kainate (a), 4-AHCP (b) and thio-ATPA (c) are green. See Supplementary Table 5 for statistics and the distances measured using the isolated LBD-ligand crystal structures.
a r t i c l e s its free energy minimum (see Supplementary Table 5 for statistics on the distributions). These widths varied among the ligands, but there was no strong correlation with ligand type. The average values of the distributions for kainate were closer to the averages for the antagonists than to those for the full agonists. This observation is consistent with kainate being a weak partial agonist. By contrast, the averages of the distributions for 4-AHCP were closer to the averages for the full agonists than to those for the antagonists. The 4-AHCP peaks were shifted to the left relative to the full agonists, indicating a reduced capacity to open the ion channel. Surprisingly, the thio-ATPA distributions almost completely coincided with the distributions for glutamate in all but the A-C distance. For the diagonal A-C pair, thio-ATPA was shifted to the left of the full agonists. The reduced displacement solely in the A-C direction relative to glutamate may explain why thio-ATPA acts as a strong partial agonist rather than as a full agonist. When the crystal structures of LBD-glutamate and LBD-(thio-ATPA) were superimposed onto the intact GluA2 structure, most inter-lobe 2 distances were smaller for the thio-ATPA complex than for the glutamate complex (Supplementary Table 5 ).
However, the present analysis of equilibrium conformational distributions suggests that this tempered agonism stems only from reduced displacement along the diagonal A-C direction rather than from several directions. Subunit nonequivalence has also been suggested for GluK2 receptors 21 . Another noteworthy observation is that the B-D distributions (the other diagonal direction) resembled the A-D and B-C distributions with an offset distance of about 35 Å. This similarity suggests that a given ligand induces an equivalent amount of displacement in these three directions.
DISCUSSION
The analysis presented here provides a first dissection of the energetic components that govern the molecular conformations and interactions that are likely to be crucial for the function of iGluRs. Topological features in the free energy landscapes that govern closure of LBDs seem to be important for evaluating the efficacy of agonists. Although the results deduced by transposing the calculated free energy landscapes of isolated LBDs onto the full-length GluA2 receptor are partly speculative, they provide a useful roadmap for the design of experiments and interpretation of results. These receptors are allosteric proteins in which the effects triggered by ligand binding are propagated over an appreciable distance through the molecule. We have established a quantitative account of the (hidden) relationship between structure and dynamics for the LBDs using molecular dynamics free energy simulations. The conformational dynamics of LBD assemblies in complex with different ligands, deduced from the free energy landscapes, build upon the information provided by crystal structures of LBD-ligand complexes, thereby offering a more complete understanding of how the actions of full agonists, partial agonists and antagonists are associated with LBD closure. The present computational framework could be extended to the analysis of other ligand-gated receptors and their activation characteristics.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
